UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

Total Knee Arthroplasty Biomechanics

Not Applicable

Completed

Conditions: Total Knee Arthroplasty (TKA)

Interventions: Other: Preoperative Assessments
Other: Standard Physical Therapy
Behavioral: Home Strengthening Exercises

First Posted Date: 2018-09-14

Last Posted Date: 2023-11-30

Lead Sponsor: University of Florida

Target Recruit Count: 38

Registration Number: NCT03671954

Locations: 🇺🇸
UF & Shands Orthopaedics and Sports Medicine Institute, Gainesville, Florida, United States
🇺🇸
UF Health Florida Surgical Center, Gainesville, Florida, United States
🇺🇸
UF Health at the University of Florida, Gainesville, Florida, United States

and more 1 locations

Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking

Not Applicable

Completed

Conditions: Balance

Interventions: Device: experimental foot device

First Posted Date: 2018-09-10

Last Posted Date: 2021-05-03

Lead Sponsor: University of Florida

Target Recruit Count: 15

Registration Number: NCT03663816

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma

Phase 2

Completed

Conditions: Urothelial Carcinoma

Interventions: Drug: Mitomycin c

First Posted Date: 2018-09-05

Last Posted Date: 2024-11-05

Lead Sponsor: University of Florida

Target Recruit Count: 29

Registration Number: NCT03658304

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Not Applicable

Completed

Conditions: Amyotrophic Lateral Sclerosis (ALS)
Neuromuscular Diseases

Interventions: Other: Acute Intermittent Hypoxia
Other: Sham Acute Intermittent Hypoxia

First Posted Date: 2018-08-24

Last Posted Date: 2023-06-09

Lead Sponsor: University of Florida

Target Recruit Count: 29

Registration Number: NCT03645031

Locations: 🇺🇸
UF Clinical Research Center, Gainesville, Florida, United States
🇺🇸
University of Florida, Gainesville, Florida, United States

Evaluation of Trigeminal Nerve Blockade

Phase 4

Conditions: Birth Defect
Mouth Abnormalities
Cleft Palate

Interventions: Drug: Ropivacaine
Other: Sham Comparator

First Posted Date: 2018-08-15

Last Posted Date: 2024-10-11

Lead Sponsor: University of Florida

Target Recruit Count: 40

Registration Number: NCT03632044

Locations: 🇺🇸
UF Health, Gainesville, Florida, United States

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

Not Applicable

Active, not recruiting

Conditions: Adenocarcinoma of the Prostate

Interventions: Radiation: HR-A
Radiation: HR-B

First Posted Date: 2018-08-10

Last Posted Date: 2024-05-08

Lead Sponsor: University of Florida

Target Recruit Count: 100

Registration Number: NCT03624660

Locations: 🇺🇸
University of Florida Health Proton Therapy Institute, Jacksonville, Florida, United States

Daily vs. Non-Daily SBRT for NSCLC

Not Applicable

Terminated

Conditions: Non-small Cell Lung Cancer

Interventions: Radiation: Daily Stereotactic Body Radiotherapy
Radiation: Non-Daily Stereotactic Body Radiotherapy

First Posted Date: 2018-08-10

Last Posted Date: 2021-10-04

Lead Sponsor: University of Florida

Target Recruit Count: 20

Registration Number: NCT03624907

Locations: 🇺🇸
Department of Radiation Oncology Davis Cancer Pavilion, Gainesville, Florida, United States
🇺🇸
University of Florida Health Proton Therapy Institute, Jacksonville, Florida, United States

Alcohol Monitor Validation

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus (HIV)

Interventions: Device: Skyn Monitor Lab Session 1
Device: Skyn Monitor Field Test with EMA App
Device: Skyn Monitor Lab Session 2

First Posted Date: 2018-08-06

Last Posted Date: 2023-06-28

Lead Sponsor: University of Florida

Target Recruit Count: 49

Registration Number: NCT03617705

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
HealthStreet, Gainesville, Florida, United States

Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients

Phase 1

Withdrawn

Conditions: Breast Cancer

Interventions: Drug: Epidiferphane
Drug: Taxane Chemotherapy

First Posted Date: 2018-08-02

Last Posted Date: 2020-01-13

Lead Sponsor: University of Florida

Registration Number: NCT03611985

The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults

Not Applicable

Completed

Conditions: Intestinal Barrier Function

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Probiotic

First Posted Date: 2018-08-02

Last Posted Date: 2019-06-21

Lead Sponsor: University of Florida

Target Recruit Count: 39

Registration Number: NCT03611400

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy